Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 3:34 pm Sale |
2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Cormorant Asset Management LP | 1,714,269 8.450% |
-249,999 (-12.73%) |
Filing History |
| 2021-02-12 5:21 pm Purchase |
2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Azamian Bobak R. | 1,915,295 9.040% |
1,915,295 (New Position) |
Filing History |
| 2021-02-12 5:19 pm Purchase |
2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Ackermann Michael | 1,467,020 7.070% |
1,467,020 (New Position) |
Filing History |
| 2021-02-12 09:42 am Unchanged |
2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW Investments, LP | 2,463,601 12.130% |
0 (Unchanged) |
Filing History |
| 2020-10-30 5:00 pm Purchase |
2020-10-20 | 13D | Tarsus Pharmaceuticals, Inc. TARS |
Horowitz Limited Partnership VIII | 1,987,105 10.300% |
1,987,105 (New Position) |
Filing History |
| 2020-10-30 4:00 pm Purchase |
2020-10-20 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Cormorant Asset Management LP | 1,964,268 9.780% |
1,964,268 (New Position) |
Filing History |
| 2020-10-28 4:31 pm Purchase |
2020-10-20 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Vivo Capital IX, LLC | 3,245,035 16.200% |
3,245,035 (New Position) |
Filing History |
| 2020-10-26 2:16 pm Purchase |
2020-10-16 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW Investments, LP | 2,463,601 12.790% |
2,463,601 (New Position) |
Filing History |
| 2020-10-23 1:40 pm Purchase |
2020-10-20 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Frazier Life Sciences IX L.P. | 1,917,157 9.500% |
1,917,157 (New Position) |
Filing History |